Anna M Trier1, Madison R Mack1, Avery Fredman1, Masato Tamari1, Aaron M Ver Heul2, Yonghui Zhao3, Changxiong J Guo3, Oshri Avraham4, Zachary K Ford5, Landon K Oetjen1, Jing Feng3, Carina Dehner6, Dean Coble7, Asima Badic1, Satoru Joshita8, Masato Kubo9, Robert W Gereau10, Jennifer Alexander-Brett11, Valeria Cavalli4, Steve Davidson5, Hongzhen Hu3, Qin Liu3, Brian S Kim12. 1. Center for the Study of Itch & Sensory Disorders, Washington University School of Medicine, St Louis, Mo; Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, Mo. 2. Center for the Study of Itch & Sensory Disorders, Washington University School of Medicine, St Louis, Mo; Division of Allergy and Immunology, Department of Medicine, Washington University School of Medicine, St Louis, Mo. 3. Center for the Study of Itch & Sensory Disorders, Washington University School of Medicine, St Louis, Mo; Department of Anesthesiology, Department of Medicine, Washington University School of Medicine, St Louis, Mo. 4. Department of Neuroscience, Washington University School of Medicine, St Louis, Mo. 5. Department of Anesthesiology and Neuroscience Program, University of Cincinnati College of Medicine, Cincinnati, Ohio. 6. Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, Mo. 7. Division of Biostatistics, Washington University School of Medicine, St Louis, Mo. 8. Division of Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Nagano, Japan. 9. Laboratory of Cytokine Regulation, Center for Integrative Medical Science (IMS), RIKEN Yokohama Institute, Yokohama, Japan; Division of Molecular Pathology, Research Institute for Biomedical Science, Tokyo University of Science, Tokyo, Japan. 10. Department of Anesthesiology, Department of Medicine, Washington University School of Medicine, St Louis, Mo; Department of Neuroscience, Washington University School of Medicine, St Louis, Mo; Washington University Pain Center, Washington University School of Medicine, St Louis, Mo. 11. Division of Pulmonary and Critical Care, Department of Medicine, Washington University School of Medicine, St Louis, Mo. 12. Center for the Study of Itch & Sensory Disorders, Washington University School of Medicine, St Louis, Mo; Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, Mo; Department of Anesthesiology, Department of Medicine, Washington University School of Medicine, St Louis, Mo; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Mo. Electronic address: briankim@wustl.edu.
Abstract
BACKGROUND: Chronic pruritus, or itch, is common and debilitating, but the neuroimmune mechanisms that drive chronic itch are only starting to be elucidated. Recent studies demonstrate that the IL-33 receptor (IL-33R) is expressed by sensory neurons. However, whether sensory neuron-restricted activity of IL-33 is necessary for chronic itch remains poorly understood. OBJECTIVES: We sought to determine if IL-33 signaling in sensory neurons is critical for the development of chronic itch in 2 divergent pruritic disease models. METHODS: Plasma levels of IL-33 were assessed in patients with atopic dermatitis (AD) and chronic pruritus of unknown origin (CPUO). Mice were generated to conditionally delete IL-33R from sensory neurons. The contribution of neuronal IL-33R signaling to chronic itch development was tested in mouse models that recapitulate key pathologic features of AD and CPUO, respectively. RESULTS: IL-33 was elevated in both AD and CPUO as well as their respective mouse models. While neuron-restricted IL-33R signaling was dispensable for itch in AD-like disease, it was required for the development of dry skin itch in a mouse model that mirrors key aspects of CPUO pathology. CONCLUSIONS: These data highlight how IL-33 may be a predominant mediator of itch in certain contexts, depending on the tissue microenvironment. Further, this study provides insight into future therapeutic strategies targeting the IL-33 pathway for chronic itch.
BACKGROUND: Chronic pruritus, or itch, is common and debilitating, but the neuroimmune mechanisms that drive chronic itch are only starting to be elucidated. Recent studies demonstrate that the IL-33 receptor (IL-33R) is expressed by sensory neurons. However, whether sensory neuron-restricted activity of IL-33 is necessary for chronic itch remains poorly understood. OBJECTIVES: We sought to determine if IL-33 signaling in sensory neurons is critical for the development of chronic itch in 2 divergent pruritic disease models. METHODS: Plasma levels of IL-33 were assessed in patients with atopic dermatitis (AD) and chronic pruritus of unknown origin (CPUO). Mice were generated to conditionally delete IL-33R from sensory neurons. The contribution of neuronal IL-33R signaling to chronic itch development was tested in mouse models that recapitulate key pathologic features of AD and CPUO, respectively. RESULTS: IL-33 was elevated in both AD and CPUO as well as their respective mouse models. While neuron-restricted IL-33R signaling was dispensable for itch in AD-like disease, it was required for the development of dry skin itch in a mouse model that mirrors key aspects of CPUO pathology. CONCLUSIONS: These data highlight how IL-33 may be a predominant mediator of itch in certain contexts, depending on the tissue microenvironment. Further, this study provides insight into future therapeutic strategies targeting the IL-33 pathway for chronic itch.
Authors: Manouela V Valtcheva; Vijay K Samineni; Judith P Golden; Robert W Gereau; Steve Davidson Journal: J Pain Date: 2015-01-30 Impact factor: 5.820
Authors: James Meixiong; Michael Anderson; Nathachit Limjunyawong; Mark F Sabbagh; Eric Hu; Madison R Mack; Landon K Oetjen; Fang Wang; Brian S Kim; Xinzhong Dong Journal: Immunity Date: 2019-04-23 Impact factor: 31.745
Authors: Brian S Kim; Mark C Siracusa; Steven A Saenz; Mario Noti; Laurel A Monticelli; Gregory F Sonnenberg; Matthew R Hepworth; Abby S Van Voorhees; Michael R Comeau; David Artis Journal: Sci Transl Med Date: 2013-01-30 Impact factor: 17.956
Authors: Fang Wang; Anna M Trier; Fengxian Li; Seonyoung Kim; Zhen Chen; Jiani N Chai; Madison R Mack; Stephanie A Morrison; Jennifer D Hamilton; Jinok Baek; Ting-Lin B Yang; Aaron M Ver Heul; Amy Z Xu; Zili Xie; Xintong Dong; Masato Kubo; Hongzhen Hu; Chyi-Song Hsieh; Xinzhong Dong; Qin Liu; David J Margolis; Marius Ardeleanu; Mark J Miller; Brian S Kim Journal: Cell Date: 2021-01-14 Impact factor: 66.850
Authors: Hans Jürgen Solinski; Mette C Kriegbaum; Pang-Yen Tseng; Thomas W Earnest; Xinglong Gu; Arnab Barik; Alexander T Chesler; Mark A Hoon Journal: Cell Rep Date: 2019-03-26 Impact factor: 9.423